Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study - PubMed
5 hours ago
- #EBMT
- #Large B-Cell Lymphoma
- #Hematopoietic Cell Transplantation
- Allogeneic hematopoietic cell transplantation (allo-HCT) is a treatment option for T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL).
- The study is conducted by the EBMT lymphoma working party, indicating a multicenter, collaborative research effort.
- The publication references related research on outcomes using CAR-T cell therapies or salvage chemotherapy for relapsed/refractory THRLBCL.
- The authors declare no competing financial interests, which supports the objectivity of the study findings.
- The full text is available from multiple sources, facilitating access to detailed methodology and results.